Ticagrelor
Brand name: Brilinta
Rank #93 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$195.8M
Total Cost
293,897
Total Claims
$195.8M
Total Cost
10,400
Prescribers
$666
Cost per Claim
37,944
Beneficiaries
450,417
30-Day Fills
$19K
Avg Cost/Provider
28
Avg Claims/Provider
Share of Medicare Part D Spending
0.07%
of total Medicare Part D spending
$195.8M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $195.8M total
🔎 Data Overview
Average cost of $5,161 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Ticagrelor
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Abdrhman Hamo | Cardiology | Beckley, WV | 559 | $475K |
| 2 | Yili Huang | Cardiology | Elmhurst, NY | 413 | $432K |
| 3 | Nicolaos Abariotis | Cardiology | Chicago, IL | 393 | $364K |
| 4 | Majed Nounou | Interventional Cardiology | Lapeer, MI | 305 | $326K |
| 5 | Michael Krueger | Cardiology | Fresno, CA | 356 | $304K |
| 6 | Hamid Nia | Cardiology | Hackensack, NJ | 338 | $274K |
| 7 | Larry Chan | Cardiology | Upland, CA | 491 | $261K |
| 8 | Stephen Chen | Interventional Cardiology | Springfield, IL | 224 | $252K |
| 9 | Harry Balian | Cardiology | Glendale, CA | 397 | $241K |
| 10 | Saleem Husain | Cardiology | Plainfield, NJ | 256 | $238K |
| 11 | Zoheir Abdelbaki | Cardiology | Lima, OH | 248 | $218K |
| 12 | Henry Yee | Cardiology | Alhambra, CA | 319 | $217K |
| 13 | Rakesh Passi | Cardiology | East Brunswick, NJ | 205 | $209K |
| 14 | Kent Wong | Cardiology | Modesto, CA | 347 | $207K |
| 15 | Rayan Hourani | Interventional Cardiology | El Cajon, CA | 253 | $205K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 90 | Brexpiprazole (Rexulti) | $204.0M | 136,378 |
| 91 | Glatiramer Acetate (Copaxone) | $203.6M | 40,986 |
| 92 | Denosumab (Prolia) | $199.4M | 114,710 |
| 93 | Ticagrelor (Brilinta) | $195.8M | 293,897 |
| 94 | Lurasidone Hcl (Latuda) | $190.9M | 254,237 |
| 95 | Darolutamide (Nubeqa) | $188.8M | 14,375 |
| 96 | Fluticasone Propionate (Fluticasone Propionate) | $187.5M | 5,343,836 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology